NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton
saeo.net — Current Class Dates (subject to change): Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course. Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance,clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance.
Source: saeo.net #NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton #norton scientific
reblog
clintonmccage:
NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton
Current Class Dates (subject to change):
Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course.
Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance,clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance.
Source: saeo.net #NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton #norton scientific
reblog
eddiemccrane:
NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton
Current Class Dates (subject to change):
Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course.
Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance,clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance.
Source: saeo.net #NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton #norton scientific
1 note reblog
pittturvey:
Norton Scientific : Blogspot | Facebook
Fraud Prevention | NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct A Norton : Social-bookmarking.net
Current Class Dates (subject to change):
Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course.
Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance,clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance.
Class Agenda/Modules - Instructors Make a Difference
Defining Clinical Research Fraud and Misconduct
Evaluation of Case History
R.E.S.E.A.R.C.H. TM Skills Program
Advanced Auditing and Monitoring Skills for Prevention
Sunday, April 15, 2012
Monday, April 2, 2012
Symantec: Pinterest scam hooks users
Pinterest may have set the media abuzz at an interactive entertainment conference earlier this month, but according to online security firm, Symantec, scammers are also targeting the service to hook unsuspecting users with a survey based scam that could trick the unwary into giving out passwords, financial accounts and other sensitive details as well as installing malware on their PCs.
According to John McDonald, the Operations Manager of the Symantec Security Response team, the scam works by placing links in forums, article comment sections and on social networks to entice the unsuspecting to complete surveys by promising items such as gift cards or big ticket electronics.
If an unsuspecting user clicks on a scam image they're typically taken to an external website which states that in order to take advantage of the offer, they must first re-pin it onto their Pinterest board.
Doing so helps spread the scam to the wider Pinterest community, increasing its credibility as the offer is posted by a trusted and known source. When the source's followers do the same, the scam turns into a self-perpetuating cycle.
After a user re-pins the scam, they are asked to click on another link. This then redirects them to a survey scam page and asks them to fill in surveys, sign-up for subscription services, reveal personal information, or even install unwanted executables and malware that could compromise the security of their PC.
As long as the user fills out multiple marketing surveys, their rewards appear legitimate.
This is not a new ploy by scammers, with similar schemes being used on Facebook.
Security experts say that users can protect themselves in a couple of different ways, first by using an internet security package, and educating themselves (and others) against such scams.
According to McDonald being scam aware is reasonably straightforward; "don't click on links or attachments, especially shortened URLs, and don't give out personal or financial information online. A reputable company will never ask you to divulge sensitive information via an email or text message. Educate your children about online safety and encourage them to report anything suspicious. "
McDonald also adds that "if it looks too good to be true, it probably is".
Online scams are the third most prevelant type of cybercrime in New Zealand, according to figures from Norton Cybercrime Report, only out-numbered by computer viruses and social network profile hacking.
From the scammer end of the equation, the motivations for their dodgy activities are fairly straightforward.
According to Symantec, some of the Pinterest scams they've analysed lead to a cost-per-action based network. For each successful conversion, the scammer is expected to make between one and US$64. It is possible in theory that scammers could be earning anything up to a several hundred dollars per day.
Sadly, cybercriminals tend to go where the masses go, when the next big thing hits, scammers tend to hot on the heels of whatever it is. Social media and mobile are the current hotspots but McDonald adds that "With the emergence of smartphones we're starting to see cybercriminals target mobile devices far more than ever before. According to the latest Norton Cybercrime Report, 8 percent of Kiwis have been a victim of cybercrime via their mobile phone".
Symantec recommend that users review their Pinterest boards and remove pins related to scam surveys.
Wednesday, March 28, 2012
Drug shortage could affect pet surgeries
A nationwide shortage of injectable painkillers and anaesthetics could soon affect surgeries for pets.
The drugs manufactured by Sandoz Canadaare being rationed because the company cut production to meet safety standards and deal with a recent fire.
That prompted the Canadian Veterinary Medical Association and some provincial organizations, such as the College of Veterinarians of British Columbia, to send out an alert to its members telling vets that hospitals will get priority over veterinary clinics.
"It's very, very annoying because you are used to certain drugs," said Jean Gauvin, spokesman of the national veterinary organization.
"We know they're effective and now there's a learning curve with certain drugs and some drugs are coming. Some other alternatives will probably be a bit more expensive."
Gauvin also said it will be a couple of weeks before clinics turn to alternative drugs and at least a year before they get their regular supply back.
Clinics have trouble finding drugs
As a result Dr. Uschi Craigdallie with the Vancouver Animal Emergency Clinic said she is most concerned about shortages of anti-seizure medications and opiods for old pets.
"When we have to start ordering new drugs and they're not being supplied to us ... we may run into problems, he said."
The drug shortage could last from 12 to 18 months and pharmacist Allan Baker said he is getting calls from worried veterinary clinics every day.
"The most urgent cases would I suspect would get treated first and anything that can be delayed would be set back until they were able to get the drugs that they need," said Baker.
Baker says some drugs can be "compounded" or made by certified pharmacists but that can cost pet owners three to four times more.
An Ottawa veterinarian told CBC News he has never seen such a drug shortage for animal medical care.
"The extent of this is far beyond anything that I've seen. It's just the sheer size of the number of drugs that are being limited and the extent to which they’re being limited for," said Dr. Nigel Gumley from the Cedarview Animal Hospital.
Last month, Sandoz announced it was scaling back production of certain drugs — mostly painkillers, antibiotics and anaesthetics — to upgrade its Quebec facility after quality-control assessments by the FDA warned the factory fell short of its standards.
Then, to exacerbate supply concerns, a fire in the ceiling above the boiler room of Sandoz's Boucherville plant halted all production.
Norton Medical and Scientific Research & Biotechnology - FDA approves kidney cancer drug from Pfizer
FOR IMMEDIATE RELEASE
(Free-Press-Release.com) January 30, 2012 -- The medicine made by Pfizer against advanced kidney cancer was recently approved by Norton Medical and Scientific Research & Biotechnology regulators for commercial use despite a warning of possible side effects.
On Friday, the Food and Drug Administration (FDA) stated that the drug (with the generic name of axitinib) is effective in curing patients who do not show response to other drugs against kidney cancer.
(Free-Press-Release.com) January 30, 2012 -- The medicine made by Pfizer against advanced kidney cancer was recently approved by Norton Medical and Scientific Research & Biotechnology regulators for commercial use despite a warning of possible side effects.
On Friday, the Food and Drug Administration (FDA) stated that the drug (with the generic name of axitinib) is effective in curing patients who do not show response to other drugs against kidney cancer.
The advance stage of kidney cancer usually begins in the lining of the kidney's tubes. Inlyta does its work by blocking specific receptors that are involved in the growth of tumor.
According to FDA, Inlyta is already the seventh drug it approved to cure advanced cancer of the kidney since 2005.
American Cancer Society said that more than 60,000 Americans are diagnosed with kidney cancer last year and 1 out of 5 is expected to die from them.
The FDA approval has come as a welcome opportunity for Pfizer since they have lost revenue from their cholesterol drug, Lipitor, after generic counterparts started to come out last year.
According to FDA, Inlyta is already the seventh drug it approved to cure advanced cancer of the kidney since 2005.
American Cancer Society said that more than 60,000 Americans are diagnosed with kidney cancer last year and 1 out of 5 is expected to die from them.
The FDA approval has come as a welcome opportunity for Pfizer since they have lost revenue from their cholesterol drug, Lipitor, after generic counterparts started to come out last year.
However, Inlyta will still face tough competition from the 6 other drugs for kidney cancer that have their respective market shares already.
An advisory committee of FDA endorsed the oral drug last month and announced that it is as effective and as safe as the kidney cancer medication from Bayer AG, Nexavar.
Generally, in clinical trials made by Norton Medical and Scientific Research & Biotechnology, Inlyta slowed the growth of cancer by 2 months versus Nexavar for patients who have already been cured for renal cell carcinoma.
An advisory committee of FDA endorsed the oral drug last month and announced that it is as effective and as safe as the kidney cancer medication from Bayer AG, Nexavar.
Generally, in clinical trials made by Norton Medical and Scientific Research & Biotechnology, Inlyta slowed the growth of cancer by 2 months versus Nexavar for patients who have already been cured for renal cell carcinoma.
However, the results differed based on what certain medicines patients have taken prior. For people who took first the Sutent (also from Pfizer), Inlyta slowed the spread of disease only by one and a half months, compared to the more than 5 months for patients treated with cytokines beforehand.
Most of the advisers of FDA stated that the drug does not have a huge advantage over others. However, the fact that it has different side effects than the other medicine in the market could be an important deciding factor for patients.
Several of the most common side effects of using Inlyta include high blood pressure, weight loss, vomiting, loss of voice and diarrhea. Some patients also reported bleeding problems that can possibly lead to fatality in extreme cases.
Most of the advisers of FDA stated that the drug does not have a huge advantage over others. However, the fact that it has different side effects than the other medicine in the market could be an important deciding factor for patients.
Several of the most common side effects of using Inlyta include high blood pressure, weight loss, vomiting, loss of voice and diarrhea. Some patients also reported bleeding problems that can possibly lead to fatality in extreme cases.
FDA issued a warning to patients with high blood pressure, intestinal bleeding, or untreated brain tumors in their intake of Inlyta.
Meanwhile, Pfizer is conducting further tests of Inlyta for liver cancer treatment.
Meanwhile, Pfizer is conducting further tests of Inlyta for liver cancer treatment.
Monday, March 26, 2012
Norton Scientific Reviews- Presentation
Slide 1
Norton Scientific Reviews: Scammers’ Valentine Treat A global security company issued a scam warning against spam messages with catchy subject lines for Internet users this Valentine’s season. Users must be extra careful in opening messages in their email accounts especially during the holidays as they can receive spam mails meant to get their attention and steal their personal data. One such scam warning issued by an antivirus company describes email messages that invites users to buy a gift for his/her loved one for Valentine’s using an attached discount coupon from Groupon. Even though the proliferation of coupon services is not totally an illegal method, their popularity comes with the risk of being used in phishing attacks. Phishing can be done by sending a massive amount of email messages asking people to enter their details on a bogus website — one that looks very similar to the popular auction sites, social networking sites and online payment sites. They are designed to obtain personal details like passwords, credit card information, etc. Through including links in email messages, scammers trick users into visiting malicious sites and online stores, obtaining personal data along the way. Most of the time, the website the link points to is not even connected to the email message but only shows the user promotional content. This is the scammer’s illegal way of earning money called click fraud — they earn for every user they have redirected to a certain website. There is also scam making the rounds in Germany involving gift coupons, distributed through Facebook, purporting to be from Amazon. Spywares and malwares are malicious programs that install themselves on a computer unit to record a user’s activity. Eventually, they will send the logs they have collected back to the scammer who plans on pilfering the data for online crimes. Scammers are freely exploiting different online platforms like Orkut, Myspace, Google+ and Twitter to cast their net on millions of users. Yet another malicious spam has been spreading on Facebook, and like its predecessors, it makes use of users’ walls to post the fake message. The post might appear harmless to most users as it only poses an invitation to install a Valentine’s Day theme for their Facebook profile. However, once a user clicks the malicious post, they will be redirected to a different webpage containing the install button. Clicking install will not do any change to your profile though; worse, it will install a malware file that will show various ads and surveys and download an extension to monitor the user’s online behavior.
Slide 2
Norton Scientific Reviews: Symantec source code leaked by hackers A group of hackers who call themselves the Lords of Dharmaraja, (and is associated with Anonymous) have published the source code of Symantec, a digital security firm know for the Norton antivirus program and pcAnywhere, raising concerns that others could exploit the security holes and try to control the users computer. The release of the source code came after the ‘extortion’ attempt failed as Symantec did not comply with their numerous deadlines. Negotiations through email messages between a representative of the hacker group, YamaTough, and someone from Symantec were also released online. The exchange of messages are about Symantec’s offer to pay USD 50,000 for the hackers to stop disclosing the source code and announce to the public that the whole Symantec hack was a fake, which made them a subject of mockery for appearing to buy protection. Both sides admitted that their participation was just a trick. The hackers denied any extortion aim, saying that they never intended to take the money and were going to publish the source code whatever happens; they simply want to humiliate them so they played along. While Symantec said that they are not actually the one in communication with the hacker, but a law enforcement agent. The long negotiation worked to the favor of Symantec as they have been able to come up with patches to their Norton and pcAnywhere programs. Symantec has advised their users to stop using the softwares in the meantime until they have issued more patches for them. Symantec released a statement saying that they have always been prepared for the leak of the source code so they’ve made and distributed hotfixes on January to secure their users. The drawn-out negotiation is an obvious sign of a law enforcer on the other line. Delaying tactics is one of their assets to obtain insight into the enemy. More importantly, it will create more transactions where paper trail will be left along the way — utilizing persons who have been involved in the process and the records themselves to trace the suspects. It has been a common ploy of investigators like the FBI who deal with kidnappers or extortionists to break down the amount into several smaller payouts. Since 2006, Symantec has already suspected there has been a network breach but they were not able to verify any data pilfering until recently when the hackers threatened them to release the source code of Norton. There are further reports saying that the source code of Symantec was stolen from servers of India’s intelligence and military department. (They alleges that Symantec has previously given India the code to guarantee the government that they contain no malicious program.) However, this was denied by Symantec — they have already admitted that the theft happened in their own servers and network. The security firm formerly said that the Indian group was also the one responsible for the 2006 breach but retracted it today. They are now saying they’re not sure who stole the source code in 2006 and how they managed to get their hands on it.
Movies on TV, Tonight & Sunday
SATURDAY EVENING
6: 00 (29) Rating 2 Fear Mark Wahlberg. A teen's family is terrorized by her psychotic boy friend. (2hrs.)
(31) Rating 2 Rambo Sylvester Stallone. A clergyman persuades Rambo to rescue captive missionaries in Burma. (2hrs.)
(38) Rating 2 Pride and Glory Edward Norton. A detective probes a fatal drug bust involving his brother. (2hrs.30mins.)
(39) Rating 3 The Goodbye Girl Richard Dreyfuss. A single mother and a wouldbe actor share an apartment. (2hrs.)
(43) Rating 3 O Brother, Where Art Thou? George Clooney. Three escaped convicts embark on an unusual odyssey. (2hrs.30mins.)
(105) Rating 3 Doubt Meryl Streep. A nun and a priest clash over allegations of child abuse. (2hrs.)
6: 10 (165) Rating 2 Footloose Kevin Bacon. Hip teen moves to town where pastor taboos dancing. (1hr.50mins.)
6: 30 (101) S.W.A.T. Firefight Gabriel Macht. An assassin tries to eliminate a Detroit SWAT unit. (1hr. 30mins.)
7: 00 (61) Rating 1 Couples Retreat Vince Vaughn. Four Midwestern couples descend on an island resort. (2hrs.30mins.)
7: 20 (100) Rating 3 Tangled Voices of Mandy Moore. Animated. A bandit provides Rapunzel's ticket out of her prison tower. (1hr.40mins.)
7: 25 (166) Rating 2 Problem Child 2 John Ritter. Unruly Junior meets his match. (1hr. 35mins.)
7: 30 (57) Rating 2 Two Weeks Notice Sandra Bullock. A millionaire confronts his feelings for his lawyer. (2hrs.30mins.)
7: 35 (102) Rating 2 Eat Pray Love Julia Roberts. A divorcee embarks on a global quest to change her life. (2hrs.25mins.)
8: 00 (31) Rating 2 Payback Mel Gibson. A betrayed thief launches a single-minded quest for revenge. (2hrs.30mins.)
(39) Rating 2 Under the Yum Yum Tree Jack Lemmon. A landlord plots to deflower a nubile new tenant. (2hrs.)
(101) Collision Earth Kirk Acevedo. The planet Mercury is on a trajectory to crash into Earth. (1hr. 30mins.)
(165) Rating 3 Cliffhanger Sylvester Stallone. A rescue becomes a hunt for stolen money. (1hr. 55mins.)
Multiply - Fraud Prevention | NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct
Current Class Dates (subject to change):
Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course.
Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance,clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance.
Class Agenda/Modules - Instructors Make a Difference
Defining Clinical Research Fraud and Misconduct
Evaluation of Case History
R.E.S.E.A.R.C.H. TM Skills Program
Advanced Auditing and Monitoring Skills for Prevention
Case Development
Typical Class Attendee -
Sponsor Auditors
Contract Research Organization Auditors
Clinical Research Associates and Monitors
Institutional Review Board Internal Auditors
Food and Drug Administration Investigators
Independent Consultant Auditors
Compliance Auditors
Experience Level - Advanced; CRC, CRA or Auditor position for two years, preferably with a four year medical or science degree
Class Price - $1500 (10% Southeast Regional Discount and 10% multiple persons from the same organization discounts are available) » Multiply - Fraud Prevention | NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct
Scheduled as Needed based on Student Demand. Email us atonlinetrain@nortonaudits.com if you are interested in this course.
Description - This is an advanced-level class that takes an in-depth examination of severe noncompliance,clinical data fabrication and falsification, scientific misconduct and fraud cases. The course focus is on developing skills for preventing fraud and misconduct and preparing clinical research professionals to better handle severe noncompliance.
Class Agenda/Modules - Instructors Make a Difference
Defining Clinical Research Fraud and Misconduct
Evaluation of Case History
R.E.S.E.A.R.C.H. TM Skills Program
Advanced Auditing and Monitoring Skills for Prevention
Case Development
Typical Class Attendee -
Sponsor Auditors
Contract Research Organization Auditors
Clinical Research Associates and Monitors
Institutional Review Board Internal Auditors
Food and Drug Administration Investigators
Independent Consultant Auditors
Compliance Auditors
Experience Level - Advanced; CRC, CRA or Auditor position for two years, preferably with a four year medical or science degree
Class Price - $1500 (10% Southeast Regional Discount and 10% multiple persons from the same organization discounts are available) » Multiply - Fraud Prevention | NORTON SCIENTIFIC SCAM-Detection and Prevention of Clinical Research Fraud and Misconduct
Subscribe to:
Posts (Atom)
